Mariëlle I. Gallegos-Ruiz

Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer

Fabrice Barlési, Giuseppe Giaccone, Mariëlle I. Gallegos-Ruiz et al. · Journal of Clinical Oncology · 2007 · 280 citations

Life Sciences, Molecular Biology, Oncology +14

Predictive Factors for Outcome in a Phase II Study of Gefitinib in Second-Line Treatment of Advanced Esophageal Cancer Patients

Maarten L. Janmaat, Mariëlle I. Gallegos-Ruiz, José Antonio Rodríguez et al. · Journal of Clinical Oncology · 2006 · 230 citations

Medicine, Oncology, Pharmacology +17

Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol‐3 kinase pathways in non‐small cell lung cancer cells

Maarten L. Janmaat, José Antonio Rodríguez, Mariëlle I. Gallegos-Ruiz et al. · International Journal of Cancer · 2005 · 151 citations

Medicine, Oncology, Pharmacology +17

A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations.

Duco Kramer, Mariëlle I. Gallegos-Ruiz, Egbert F. Smit et al. · PubMed · 2009 · 50 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Inherited Germline T790M Mutation and Somatic Epidermal Growth Factor Receptor Mutations in Non-small Cell Lung Cancer Patients

Carmelo Tibaldi, Elisa Giovannetti, Enrico Vasile et al. · Journal of Thoracic Oncology · 2011 · 47 citations · Full text

Life Sciences, Genetics, Oncology +14